Role of ABCG2/BCRP in biology and medicine

被引:281
作者
Krishnamurthy, P [1 ]
Schuetz, JD [1 ]
机构
[1] St Jude Childrens Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA
关键词
ABC transporter; hypoxia; stem cells; cancer; drug resistance; heme;
D O I
10.1146/annurev.pharmtox.46.120604.141238
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The protein variously named ABCG2/BCRP/MXR/ABCP is a recently described ATP-binding cassette (ABC) transporter originally identified by its ability to confer drug resistance that is independent of Mrp1 (multidrug-resistance protein 1) and Pgp (P-glycoprotein). Unlike Mrp1 and Pgp, ABCG2 is a half-transporter that must homodimerize to acquire transport activity. ABCG2 is found in a variety of stem cells and may protect them from exogenous and endogenous toxins. ABCG2 expression is upregulated under low-oxygen conditions, consistent with its high expression in tissues exposed to low-oxygen environments. ABCG2 interacts with heme and other porphyrins and protects cells and/or tissues from protoporphyrin accumulation under hypoxic conditions. Individuals who carry ABCG2 alleles that have impaired function may be more susceptible to porphyrin-induced toxicity. Abcg2 knock-out models have allowed in vivo studies of Abcg2 function in host and cellular defense. In combination with immunohistochemical analyses, these studies have revealed how ABCG2 influences the absorption, distribution, and excretion of drugs and cytotoxins.
引用
收藏
页码:381 / 410
页数:32
相关论文
共 179 条
[61]  
Honjo Y, 2001, CANCER RES, V61, P6635
[62]   Imatinib mesylate is a potent inhibitor of the ABCG2 (BCRP) transporter and reverses resistance to topotecan and SN-38 in vitro [J].
Houghton, PJ ;
Germain, GS ;
Harwood, FC ;
Schuetz, JD ;
Stewart, CF ;
Buchdunger, E ;
Traxler, P .
CANCER RESEARCH, 2004, 64 (07) :2333-2337
[63]   Folate deprivation results in the loss of breast cancer resistance protein (BCRP/ABCG2) expression - A role for BCRP in cellular folate homeostasis [J].
Ifergan, I ;
Shafran, A ;
Jansen, G ;
Hooijberg, JH ;
Scheffer, GL ;
Assaraf, YG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (24) :25527-25534
[64]  
Imai Y, 2005, CANCER RES, V65, P596
[65]   Breast cancer resistance protein exports sulfated estrogens but not free estrogens [J].
Imai, Y ;
Asada, S ;
Tsukahara, S ;
Ishikawa, E ;
Tsuruo, T ;
Sugimoto, Y .
MOLECULAR PHARMACOLOGY, 2003, 64 (03) :610-618
[66]  
Itoda Masaya, 2003, Drug Metab Pharmacokinet, V18, P212, DOI 10.2133/dmpk.18.212
[67]   Arginine-482 is not essential for transport of antibiotics, primary bile acids and unconjugated sterols by the human breast cancer resistance protein (ABCG2) [J].
Janvilisri, T ;
Shahi, S ;
Venter, H ;
Balakrishnan, L ;
Van Veen, HW .
BIOCHEMICAL JOURNAL, 2005, 385 :419-426
[68]   Sterol transport by the human breast cancer resistance protein (ABCG2) expressed in Lactococcus lactis [J].
Janvilisri, T ;
Venter, H ;
Shahi, S ;
Reuter, G ;
Balakrishnan, L ;
van Veen, HW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (23) :20645-20651
[69]   The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria [J].
Jonker, JW ;
Buitelaar, M ;
Wagenaar, E ;
van der Valk, MA ;
Scheffer, GL ;
Scheper, RJ ;
Plösch, T ;
Kuipers, F ;
Elferink, RPJO ;
Rosing, H ;
Beijnen, JH ;
Schinkel, AH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (24) :15649-15654
[70]   Role of breast cancer resistance protein in the bioavailability and fetal penetration of topotecan [J].
Jonker, JW ;
Smit, JW ;
Brinkhuis, RF ;
Maliepaard, M ;
Beijnen, JH ;
Schellens, JHM ;
Schinkel, AH .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (20) :1651-1656